Role of Pegylated Interferon in Combination With DAAs to Cure Hepatitis C As Soon As Possible - Hepatitis C [ASAP-C]

Clinical trial NCT03480932 · COMPLETED

Trial details

NCT number: NCT03480932
Sponsor: Johns Hopkins Bloomberg School of Public Health
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2018-02-02
Primary completion: 2018-11-02
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.